Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
1990-10-11
pubmed:abstractText
The three-dimensional structure of bovine lens leucine aminopeptidase (EC 3.4.11.1) complexed with bestatin, a slow-binding inhibitor, has been solved to 3.0-A resolution by the multiple isomorphous replacement method with phase combination and density modification. In addition, the structure of the isomorphous native enzyme has been refined at 2.7-A resolution, and the current crystallographic R factor is 0.169 for a model that includes the two zinc ions and all 487 amino acid residues comprising the asymmetric unit. The enzyme is physiologically active as a hexamer, which has 32 symmetry and is triangular in shape with a triangle edge length of 115 A and maximal thickness of 90 A. The monomers are crystallographically equivalent and each is folded into two unequal alpha/beta domains connected by an alpha-helix to give a comma-like shape with approximate maximal dimensions of 90 x 55 x 55 A3. The secondary structural composition is 40% alpha-helix and 19% beta-strand. The N-terminal domain (160 amino acids) mediates trimer-trimer interactions and does not appear to participate directly in catalysis. The C-terminal domain (327 amino acids) is responsible for catalysis and binds the two zinc ions, which are 2.88 A apart. The pair of metal ions is located near the edge of an eight-stranded, saddle-shaped beta-sheet. One zinc ion is coordinated by carboxylate oxygen atoms of Asp-255, Asp-332, and Glu-334 and the carbonyl oxygen of Asp-332. The other zinc ion is coordinated by the carboxylate oxygen atoms of Asp-255, Asp-273, and Glu-334. The active site also contains two positively charged residues, Lys-250 and Arg-336. The six active sites are themselves located in the interior of the hexamer, where they line a disk-shaped cavity of radius 15 A and thickness 10 A. Access to this cavity is provided by solvent channels that run along the twofold symmetry axes.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-1012015, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-17810339, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-2798408, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-3001478, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-3041592, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-3141408, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-3681996, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-3704639, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-3709525, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-3841179, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-3853075, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-4079768, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-4079800, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-458936, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-4692835, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-4882249, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-5066408, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-510547, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-6209279, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-6615800, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-7085616, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-7120407, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-881727, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-926176, http://linkedlifedata.com/resource/pubmed/commentcorrection/2395881-931798
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6878-82
pubmed:dateRevised
2010-9-9
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Molecular structure of leucine aminopeptidase at 2.7-A resolution.
pubmed:affiliation
Gibbs Chemical Laboratory, Harvard University, Cambridge, MA 02138.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't